Abstract
Six of eight patients with obsessive-compulsive disorder had an exacerbation of symptoms when given m-chlorophenylpiperazine. Fenfluramine and placebo produced mild improvement. Six patients given intravenous clonidine experienced marked reduction in obsessions. Implications for serotonergic and noradrenergic hypotheses of obsessive-compulsive disorder are discussed.
Original language | English (US) |
---|---|
Pages (from-to) | 1015-1017 |
Number of pages | 3 |
Journal | American Journal of Psychiatry |
Volume | 145 |
Issue number | 8 |
DOIs | |
State | Published - 1988 |
Externally published | Yes |
ASJC Scopus subject areas
- Psychiatry and Mental health